中国药理学会, 常务理事/Chinese Pharmacological Society, Executive Member of the Council

中国药理学会心血管药理专业委员会, 常务委员/Cardiovascular Pharmacology Committee of the Chinese Pharmacological Society, Executive Member of the Committee

研究方向为心血管药物药理学，主要涉及心血管炎症和代谢相关损伤👃。以通讯或共同通讯作者在Acta Pharmacol Sin, Arterioscler Thromb Vasc Biol, Anesthesiology, Hypertension, Redox Biology, Eur Heart J等发表文章30余篇🧛🏻‍♂️。获国家自然科学基金7项、上海市科委科技创新等资助15项。曾获中国药理学会Servier奖、国家自然科学二等奖(第3)等奖励。

The major area of Dr. Shen is related to cardiovascular pharmacology mainly focused on inflammation and metabolism-related cardiovascular damage. His research has been funded by National Natural Science Foundation of China, Natural Science Foundation of Shanghai etc. As a corresponding author, he published more than 30 papers including Acta Pharmacol Sin, Arterioscler Thromb Vasc Biol, Anesthesiology, Hypertension, Redox Biology, Eur Heart J etc. He was awarded the Servier Prize in pharmacology, shared the National Natural Science Prize (second class, ranked 3) etc.